Market Cap 272.14M
Revenue (ttm) 0.00
Net Income (ttm) 3.75M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 892,700
Avg Vol 1,767,928
Day's Range N/A - N/A
Shares Out 1.38B
Stochastic %K 51%
Beta 1.18
Analysts Strong Buy
Price Target $4.00

Company Profile

CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company's leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. It has...

Industry: Biotechnology
Sector: Healthcare
Phone: 360 980 8524
Fax: 360 799 5954
Address:
1111 Main Street, Suite 660, Vancouver, United States
fibonacci1170
fibonacci1170 Aug. 19 at 12:12 PM
$CYDY I keep buying more and more shares, slowly. Why? Macaque infants are similar to human infants. The day a human infant is shown to be cleared of all HIV from the body (functional cure), the news will reverberate in every corner of the planet 🌎 Quadruple digits 🧨🧨🧨🧨
0 · Reply
geetee12345
geetee12345 Aug. 19 at 11:11 AM
$CYDY GM Fam, I watched a new day rise today, hope you all have a blessed day :)
0 · Reply
u2rocksme
u2rocksme Aug. 19 at 8:33 AM
$CYDY EXTREMELY BULLISH!!!
0 · Reply
GhostofCytomight
GhostofCytomight Aug. 19 at 3:26 AM
$CYDY I WILL TAKE 20-40‼️😂
1 · Reply
Nyasaland
Nyasaland Aug. 19 at 3:02 AM
$CYDY hi team. These are tough times. Some of us have tough things in our lives ongoing, but I truly believe in the power of positivity, confidence in Leronlimab and finally validation. Where we are is where we are but where we are going is like Elon Musk to Mars. #no
1 · Reply
bellaboos
bellaboos Aug. 19 at 2:49 AM
0 · Reply
SzewczRock_79
SzewczRock_79 Aug. 19 at 1:59 AM
0 · Reply
GhostofCytomight
GhostofCytomight Aug. 19 at 1:41 AM
$CYDY LETS SEE ‼️🫡
3 · Reply
CapitalMonk
CapitalMonk Aug. 19 at 1:36 AM
$CYDY Price: $0.20 (-1.55%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±3.58% RSI: 60.4 | Momentum: Strong Momentum Volume: -84.5% vs avg Volatility: 2.86% Support: $0.18 | Resistance: $0.22 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
GhostofCytomight
GhostofCytomight Aug. 19 at 1:28 AM
$CYDY 🤞🏼
0 · Reply
Latest News on CYDY
No data available.
fibonacci1170
fibonacci1170 Aug. 19 at 12:12 PM
$CYDY I keep buying more and more shares, slowly. Why? Macaque infants are similar to human infants. The day a human infant is shown to be cleared of all HIV from the body (functional cure), the news will reverberate in every corner of the planet 🌎 Quadruple digits 🧨🧨🧨🧨
0 · Reply
geetee12345
geetee12345 Aug. 19 at 11:11 AM
$CYDY GM Fam, I watched a new day rise today, hope you all have a blessed day :)
0 · Reply
u2rocksme
u2rocksme Aug. 19 at 8:33 AM
$CYDY EXTREMELY BULLISH!!!
0 · Reply
GhostofCytomight
GhostofCytomight Aug. 19 at 3:26 AM
$CYDY I WILL TAKE 20-40‼️😂
1 · Reply
Nyasaland
Nyasaland Aug. 19 at 3:02 AM
$CYDY hi team. These are tough times. Some of us have tough things in our lives ongoing, but I truly believe in the power of positivity, confidence in Leronlimab and finally validation. Where we are is where we are but where we are going is like Elon Musk to Mars. #no
1 · Reply
bellaboos
bellaboos Aug. 19 at 2:49 AM
0 · Reply
SzewczRock_79
SzewczRock_79 Aug. 19 at 1:59 AM
0 · Reply
GhostofCytomight
GhostofCytomight Aug. 19 at 1:41 AM
$CYDY LETS SEE ‼️🫡
3 · Reply
CapitalMonk
CapitalMonk Aug. 19 at 1:36 AM
$CYDY Price: $0.20 (-1.55%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±3.58% RSI: 60.4 | Momentum: Strong Momentum Volume: -84.5% vs avg Volatility: 2.86% Support: $0.18 | Resistance: $0.22 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
GhostofCytomight
GhostofCytomight Aug. 19 at 1:28 AM
$CYDY 🤞🏼
0 · Reply
BioHunter1
BioHunter1 Aug. 18 at 10:56 PM
$CYDY CYDY has the goods. waiting to see whats inside the big cake
0 · Reply
WheelsAreRolling
WheelsAreRolling Aug. 18 at 9:19 PM
$CYDY You can’t Stop What’s Coming
0 · Reply
mazzystar1
mazzystar1 Aug. 18 at 9:11 PM
$CYDY uh-oh... here we go again!!! (even with low volume!!!)
0 · Reply
Twinter11
Twinter11 Aug. 18 at 8:31 PM
$CYDY https://www.thelundreport.org/content/ohsu-study-new-three-pronged-treatment-clears-hiv-infants ...“The shocking thing was that it did work, and it worked remarkably well. Oftentimes in research, you get results where it's a shade of gray,” said Jonah Sacha, professor and chief of pathobiology and immunology at OHSU’s Oregon National Primate Research Center and Vaccine and Gene Therapy Institute, in a video call with The Lund Report. “This was 100%. It was wholly a black-and-white result.”... "“Curing HIV is like trying to hit a double bullseye on a dart board, and doing it in the dark. But if we can define the mechanism of it and know how this works, then you switch the light on and you can see the dartboard. You know where you're throwing the dart. It’s still difficult, but at least you have an idea of what your target looks like and where you're trying to attack.”
1 · Reply
GhostofCytomight
GhostofCytomight Aug. 18 at 8:18 PM
1 · Reply
Sbowers59
Sbowers59 Aug. 18 at 8:08 PM
$CYDY Big day tomorrow!!! ⬆️
2 · Reply
my69z
my69z Aug. 18 at 8:03 PM
$CYDY The global immune checkpoint inhibitors market is valued at approximately $48 billion to $58 billion. Cumulative historical sales since the commercialization of the first checkpoint inhibitors (such as Yervoy in 2011 and Keytruda/Opdivo in 2014) scale well past $250 billion to $300 billion, heavily driven by blockbuster PD-1/PD-L1 monoclonal antibody franchises." Now multiply the coming yearly & future cumulative valuations due to Leronlimab ...
0 · Reply
my69z
my69z Aug. 18 at 7:53 PM
$CYDY The longer our Leronlimab Stand-alone goes on the TME & other environments, the deeper our SOC gets embedded against any future drug attempting to claim a "significant improvement".....as a Stand-alone or etc... ...
0 · Reply
GhostofCytomight
GhostofCytomight Aug. 18 at 7:41 PM
$CYDY ME HEARING PEOPLE IN JANUARY TALKING ABOUT THIS NEW DRUG CALLED LERONLIMAB THAT IS CRUSHING SOLID TUMORS‼️🙌🏼
2 · Reply
my69z
my69z Aug. 18 at 7:30 PM
$CYDY Take the entire ICI industry historical values, & the next ICI industries value, is multiples higher than that Courtesy of: Leronlimab. ...
0 · Reply
Twinter11
Twinter11 Aug. 18 at 7:24 PM
$CYDY "tres tratamientos con funciones diferentes: terapia antirretroviral, anticuerpos neutralizantes de amplio espectro y leronlimab" https://canal1.com.ar/una-combinacion-de-tres-farmacos-logro-eliminar-el-vih-en-primates-recien-infectados/
0 · Reply
Coyote_7
Coyote_7 Aug. 18 at 7:13 PM
$CYDY September 2025 "It is fortuitous that we launched the CRC study just as the PD-L1 data came to light, as it allows us to immediately commence efforts to collect certain prospective confirmatory data." Dr. J They must know by now!!! 🔥
2 · Reply